TABLE 3.
Molecular function enrichment of gene expression changes in confluent HFFs upon tachyzoite infection
GO term | Function | Padj |
---|---|---|
Upregulated | ||
GO:0003677 | DNA binding | 2.26E−13 |
GO:0046982 | Protein heterodimerization activity | 2.74E−11 |
GO:0042393 | Histone binding | 5.18E−11 |
GO:0097159 | Organic cyclic compound binding | 5.58E−08 |
GO:1901363 | Heterocyclic compound binding | 5.97E−08 |
GO:0003676 | Nucleic acid binding | 1.08E−05 |
GO:0036094 | Small molecule binding | 5.55E−05 |
GO:0000166 | Nucleotide binding | 1.07E−04 |
GO:1901265 | Nucleoside phosphate binding | 1.12E−04 |
GO:0035575 | Histone demethylase activity (H4-K20 specific) | 1.44E−04 |
GO:0003688 | DNA replication origin binding | 4.10E−04 |
GO:0003678 | DNA helicase activity | 5.19E−04 |
GO:0005515 | Protein binding | 9.61E−04 |
GO:0097367 | Carbohydrate derivative binding | 1.43E−03 |
GO:0003697 | Single-stranded DNA binding | 3.77E−03 |
GO:0043168 | Anion binding | 4.58E−03 |
GO:0032451 | Demethylase activity | 4.89E−03 |
GO:0005488 | Binding | 5.93E−03 |
GO:0005200 | Structural constituent of cytoskeleton | 9.56E−03 |
GO:0032405 | MutLalpha complex binding | 1.03E−02 |
GO:0050501 | Hyaluronan synthase activity | 4.11E−02 |
Downregulated | ||
GO:0005539 | Glycosaminoglycan binding | 3.81E−03 |
GO:0005518 | Collagen binding | 3.10E−02 |
GO:0036122 | BMP bindinga | 3.10E−02 |
GO:0048018 | Receptor agonist activity | 3.32E−02 |
BMP, bone morphogenetic protein.